A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors

NCT07205718 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

223

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced or Metastatic Solid Tumors

Interventions

DRUG: TAK-188

Sponsor

Takeda